German CDMO BioSpring is building a new production facility that it hopes will become one of the world's biggest manufacturing sites for DNA- and RNA-based active pharmaceutical ingredients (API). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback